Abstract
Mesenchymal stromal stem cells (MSSCs) are a unique object for the development of new methods for the treatment of multiple sclerosis (MS) due to their immunomodulatory properties, stimulation of repair and transdifferentiation processes under certain conditions in the direction of glial cells and even neurons. The article presents the results of a study aimed at assessing the effect of allogeneic MSSC transplantation on some immunological parameters of patients with MS. The most significant changes in the immunological status were observed by 6 months of the post-transplantation period. After therapy with allogeneic MSSCs, there was no pronounced inhibition of the functional state of T-lymphocytes in response to nonspecific stimulation, which indicates the functional viability of immune system cells in maintaining antigenic homeostasis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
